A drug with the SMILES CCN(CC)P(=O)(Nc1ccc(Br)cc1)c1c(C)nn(CCC#N)c1NC(=O)c1ccc(Cl)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 7.192%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCN(CC)P(=O)(Nc1ccc(Br)cc1)c1c(C)nn(CCC#N)c1NC(=O)c1ccc(Cl)cc1
CCN(CC)P(=O)(Nc1ccc(Br)cc1)c1c(C)nn(CCC#N)c1NC(=O)c1ccc(Cl)cc1
N-[4-[(4-bromoanilino)-(diethylamino)phosphoryl]-2-(2-cyanoethyl)-5-methylpyrazol-3-yl]-4-chlorobenzamide